Whole genome sequencing analysis identifies recurrent structural alterations in esophageal squamous cell carcinoma

Author:

Dutta Munmee12,Nakagawa Hidewaki3,Kato Hiroaki4,Maejima Kazuhiro3,Sasagawa Shota3,Nakano Kaoru3,Sasaki-Oku Aya3,Fujimoto Akihiro5,Mateos Raúl Nicolás12,Patil Ashwini2,Tanaka Hiroko2,Miyano Satoru26,Yasuda Takushi4,Nakai Kenta12,Fujita Masashi3

Affiliation:

1. Department of Computational Biology and Medical Sciences, Graduate school of Frontier Sciences, The University of Tokyo, Chiba, Japan

2. Human Genome Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan

3. Laboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan

4. Department of Surgery, Faculty of Medicine, Kindai University, Osaka, Japan

5. Department of Drug Discovery Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan

6. Health Intelligence Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan

Abstract

Esophageal squamous cell carcinoma (ESCC) is the predominant type of esophageal cancer in the Asian region, including Japan. A previous study reported mutational landscape of Japanese ESCCs by using exome sequencing. However, somatic structural alterations were yet to be explored. To provide a comprehensive mutational landscape, we performed whole genome sequencing (WGS) analysis of biopsy specimens from 20 ESCC patients in a Japanese population. WGS analysis identified non-silent coding mutations of TP53, ZNF750 and FAT1 in ESCC. We detected six mutational signatures in ESCC, one of which showed significant association with smoking status. Recurrent structural variations, many of which were chromosomal deletions, affected genes such as LRP1B, TTC28, CSMD1, PDE4D, SDK1 and WWOX in 25%–30% of tumors. Somatic copy number amplifications at 11q13.3 (CCND1), 3q26.33 (TP63/SOX2), and 8p11.23 (FGFR1) and deletions at 9p21.3 (CDKN2A) were identified. Overall, these multi-dimensional view of genomic alterations improve the understanding of the ESCC development at molecular level and provides future prognosis and therapeutic implications for ESCC in Japan.

Funder

Japan Agency for Medical Research and Development

Project for Cancer Research and Therapeutic Evolution

JSPS KAKENHI

Japanese Government Scholarship

Publisher

PeerJ

Subject

General Agricultural and Biological Sciences,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3